当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2012年第35期 > 正文
编号:12352853
蛋白酶激活受体—2与抑癌基因P53、人表皮生长因子受体—2在乳腺癌组织中的表达及其意义(3)
http://www.100md.com 2012年12月15日 陆奕宇 苏式兵
第1页

    参见附件。

     [4] MorriS DR,Ding Y,Ricks TK et al. Protease-activated receptor-2 is essential for factor Ⅶa and Ⅹa-induced signaling,migration,and invasion of breast cancer cells [J]. Cancer Res,2006,66(1):307-314.

    [5] Jahan I,Fujimoto J,Alam SM,et al. Role of protease activatedreceptor-2 in tumor Advancement of ovarian cancers [J]. Ann Oncol,2007,18(9):1506-1512.

    [6] Fromowitz FB,Viola MV,Chao S,et al. Ras p21 expression in the progression of breast cancer [J]. Hum Pathol,1987,18(12):1268-1275.

    [7] Su S,Li Y,Luo Y,et al. Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration [J]. Oncogene,2009,28(34):3047-3057.

    [8] Fujimoto D,Hirono Y,Goi T,et al. Expression of protease activated receptor-2(PAR-2) in gastric cancer [J]. J Surg Oncol,2006,93(2):139-144.

    [9] 邓元,张学斌,王鸿雁,等.乳腺癌组织中核转录因子NF-κB和抑癌基因P53的表达及其意义[J].肿瘤防治研究,2007,(5):342-346.

    [10] Kumaraguruparan R,Prathiba D,Nagini S. Of humans and canines:Immunohisto-chemical analysis of PCNA,Bcl-2,P53,cytokeratin and ER in mammary tumours [J]. Res Vet Sci,2006,81(2):218-224.

    [11] 李宝江,朱志华,王军业,等.Ki-67、P53、VEGF和cerbB-2在乳腺癌组织中表达的相关性研究及其临床意义[J] ......

您现在查看是摘要介绍页,详见PDF附件(3749kb)